Gain Therapeutics
GANX
GANX
16 hedge funds and large institutions have $3.87M invested in Gain Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $4.75M → $3.87M (-$879K)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$119K | |
| 2 | +$46.6K | |
| 3 | +$10K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.29K |
| 5 |
HI
Hoey Investments
Coatesville,
Pennsylvania
|
+$2K |
Top Sellers
| 1 | -$288K | |
| 2 | -$103K | |
| 3 | -$48K | |
| 4 |
Millennium Management
New York
|
-$44K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$39.5K |